The publication detail shows the title, authors (with indicators showing other profiled authors), information on the publishing organization, abstract and a link to the article in PubMed. This abstract is what is used to create the fingerprint of the publication. If any grants are referenced by the publication, they will be listed here as well.
[Therapeutic effect of adjuvant combination chemotherapy in the treatment of 8 cases of childhood soft-tissue sarcoma].
S Imashuku; S Todo; N Esumi; H Yamanaka; M Iwasaku; Y Morioka; S Ogita; K Tokiwa; Y Fukumochi; K Fujita (Profiled Author: Noriko Esumi)
Gan to kagaku ryoho. Cancer & chemotherapy 1987;14(4):1063-8.Abstract
The therapeutic results obtained in eight cases of childhood malignant soft-tissue sarcoma are summarized. Male to female ratio was 4:4, four were rhabdomyosarcoma and 5 were defined as Group I/II. Adjuvant combination chemotherapy was administered soon after biopsy (3 cases), or after partial or total resection (3 cases) of the primary tumor. In one case, irradiation was employed and in the remaining case, no further therapy was given after surgery. The three patients who underwent total removal of the tumor followed by adjuvant chemotherapy including adriamycin, and a patient with a partially resected intra-orbital tumor which responded well to a similar form of chemotherapy are currently alive after 26+ to 71+ months. By contrast, four patients whose tumors were too bulky to be resected responded poorly to chemotherapy and died. It must be emphasized that adjuvant chemotherapy is of limited value in the treatment of advanced childhood soft-tissue sarcoma.
This section shows information related to the publication - computed using the fingerprint of the publication - including related publications, related experts and related grants with fingerprints representing significant amounts of overlap between their fingerprint and this publication. The red dots indicate whether those experts or terms appear within the publication, thereby showing potential and actual connections.
P P Breitfeld; E Lyden; R B Raney; L A Teot; M Wharam; T Lobe; W M Crist; H M Maurer; S S Donaldson; F B Ruymann
Ifosfamide and etoposide are superior to vincristine and melphalan for pediatric metastatic rhabdomyosarcoma when administered with irradiation and combination chemotherapy: a report from the Intergroup Rhabdomyosarcoma Study Group.Journal of pediatric hematology/oncology 2001;23(4):225-33.
W M Crist; R B Raney; A Ragab; R Heyn; M Wharam; B Webber; J Johnston; M BeltangadyMedical and pediatric oncology 1987;15(2):51-7.
F B Ruymann; T Vietti; E Gehan; E Wiener; M Wharam; W A Newton; H Maurer
Cyclophosphamide dose escalation in combination with vincristine and actinomycin-D (VAC) in gross residual sarcoma. A pilot study without hematopoietic growth factor support evaluating toxicity and response.Journal of pediatric hematology/oncology 1995;17(4):331-7.
Appears in this Publication
Author of this Publication